Oncolytics Biotech Inc
ONCYNasdaqCIK 1129928HealthcareFiscal year ends Dec 31
Reports and events: 745 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2709:46 ET | 8-K | 8.01 Other events | 0001129928-26-000076 |
| 2026-10-2009:37 ET | 8-K | 8.01 Other events | 0001129928-26-000074 |
| 2026-10-1409:33 ET | 8-K | 8.01 Other events | 0001129928-26-000072 |
| 2026-10-1308:10 ET | 8-K | 8.01 Other events | 0001129928-26-000070 |
| 2026-10-0616:27 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001129928-26-000066 |
| 2026-09-2909:34 ET | 8-K | 8.01 Other events | 0001129928-26-000059 |
| 2026-09-2809:32 ET | 8-K | 8.01 Other events | 0001129928-26-000057 |
| 2026-09-1008:17 ET | 8-K | 8.01 Other events | 0001129928-26-000055 |
| 2026-08-1809:03 ET | 8-K | 8.01 Other events | 0001129928-26-000053 |
| 2026-08-1216:18 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001129928-26-000051 |
| 2026-07-2416:40 ET | 8-K | 3.01 Delisting notice | 0001129928-26-000047 |
| 2026-07-2009:03 ET | 8-K | 8.01 Other events | 0001129928-26-000045 |
| 2026-07-1309:03 ET | 8-K | 8.01 Other events | 0001129928-26-000043 |
| 2026-07-0816:23 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-26-081797 |
| 2026-06-1609:05 ET | 8-K | 8.01 Other events | 0001129928-26-000041 |
| 2026-06-0209:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001129928-26-000039 |
| 2026-06-0109:06 ET | 8-K | 8.01 Other events | 0001129928-26-000037 |
| 2026-05-2209:03 ET | 8-K | 8.01 Other events | 0001129928-26-000035 |
| 2026-05-1416:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001129928-26-000033 |
| 2026-05-0409:03 ET | 8-K | 8.01 Other events | 0001129928-26-000028 |
| 2026-04-2708:16 ET | 8-K | 8.01 Other events | 0001129928-26-000026 |
| 2026-04-0616:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-039935 |
| 2026-04-0609:24 ET | 8-K | 8.01 Other events | 0001129928-26-000024 |
| 2026-04-0109:07 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-038272 |
| 2026-03-3017:29 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001129928-26-000020 |
| 2026-03-2016:43 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-032763 |
| 2026-03-1909:05 ET | 8-K | 8.01 Other events | 0001129928-26-000011 |
| 2026-03-0210:44 ET | 8-K | 8.01 Other events | 0001129928-26-000009 |
| 2026-02-2409:10 ET | 8-K | 8.01 Other events | 0001129928-26-000006 |
| 2026-02-0412:05 ET | 8-K | 8.01 Other events | 0001129928-26-000004 |
| 2026-01-1516:21 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-004103 |
| 2026-01-1518:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-003815 |
| 2026-01-1216:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002863 |
| 2026-01-0709:04 ET | 6-K | Report of a foreign private issuerPeriod 2026-01-07 | 0001129928-26-000002 |
| 2025-12-1609:03 ET | 6-K | Report of a foreign private issuerPeriod 2025-12-16 | 0001129928-25-000097 |
| 2025-12-1018:02 ET | 6-K | Report of a foreign private issuerPeriod 2025-12-09 | 0001129928-25-000095 |
| 2025-11-2016:06 ET | 6-K | Report of a foreign private issuerPeriod 2025-11-20 | 0001129928-25-000093 |
| 2025-11-1909:02 ET | 6-K | Report of a foreign private issuerPeriod 2025-11-19 | 0001129928-25-000091 |
| 2025-11-1217:28 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-30 | 0001129928-25-000089 |
| 2025-11-0408:11 ET | 6-K | Report of a foreign private issuerPeriod 2025-11-04 | 0001129928-25-000086 |
| 2025-10-2807:43 ET | 6-K | Report of a foreign private issuerPeriod 2025-10-28 | 0001129928-25-000084 |
| 2025-10-2009:02 ET | 6-K | Report of a foreign private issuerPeriod 2025-10-20 | 0001129928-25-000081 |
| 2025-10-2021:54 ET | 6-K | Report of a foreign private issuerPeriod 2025-10-17 | 0001104659-25-100535 |
| 2025-10-1017:28 ET | 6-K | Report of a foreign private issuerPeriod 2025-10-10 | 0001104659-25-098796 |
| 2025-09-2909:08 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-29 | 0001129928-25-000079 |
| 2025-09-1608:32 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-16 | 0001129928-25-000077 |
| 2025-09-0807:30 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-08 | 0001129928-25-000074 |
| 2025-09-0209:33 ET | 6-K | Report of a foreign private issuerPeriod 2025-09-02 | 0001129928-25-000072 |
| 2025-08-2808:34 ET | 6-K | Report of a foreign private issuerPeriod 2025-08-28 | 0001129928-25-000070 |
| 2025-08-1117:14 ET | 6-K | Report of a foreign private issuerPeriod 2025-08-11 | 0001129928-25-000068 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 09:47 ET. Listed shows no prices and gives no investment advice.